PINNACLE LITE PELVIC FLOOR REPAIR KIT, POSTERIOR UPHOLD LITE VAGINAL SUPPORT SYSTEM

K122459 · Boston Scientific Corporation · OTP · Dec 13, 2012 · Obstetrics/Gynecology

Device Facts

Record IDK122459
Device NamePINNACLE LITE PELVIC FLOOR REPAIR KIT, POSTERIOR UPHOLD LITE VAGINAL SUPPORT SYSTEM
ApplicantBoston Scientific Corporation
Product CodeOTP · Obstetrics/Gynecology
Decision DateDec 13, 2012
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 884.5980
Device ClassClass 3
AttributesTherapeutic

Intended Use

The Pinnacle LITE Pelvic Floor Repair Kit is indicated for tissue reinforcement in women with pelvic organ prolapse, for transvaginal repair of posterior vaginal vault prolapse. The Uphold LITE Vaginal Support System is indicated for tissue reinforcement in women with pelvic organ prolapse, for the transvaginal repair of anterior and apical vaginal wall prolapse.

Device Story

Sterile, single-use surgical mesh kits for transvaginal pelvic organ prolapse repair. Consists of macroporous polypropylene knitted mesh with integrated legs protected by disposable polymer sleeves. Distal end of sleeve features lead with dart for use with Capio Suture Capturing Device to facilitate tissue passage. Modification involves leg assembly change: removal of mesh tack welds and separator weld; addition of second leader loop to maintain mesh leg location within sleeve. Used by surgeons in clinical settings for tissue reinforcement. Device provides structural support to vaginal wall; improves anatomical outcomes for patients with prolapse.

Clinical Evidence

Bench testing only. Testing included leg assembly flexibility, mesh/leg tensile strength, leader/dilator/sleeve tensile strength, and sleeve removal force. No clinical data provided.

Technological Characteristics

Macroporous polypropylene knitted mesh; disposable polymer sleeves; integrated legs with leader loops. Single-use, sterile. Mechanical assembly for transvaginal placement using Capio Suture Capturing Device. No software or energy source.

Indications for Use

Indicated for women with pelvic organ prolapse requiring tissue reinforcement for transvaginal repair of posterior vaginal vault prolapse (Pinnacle LITE) or anterior and apical vaginal wall prolapse (Uphold LITE).

Regulatory Classification

Identification

Surgical mesh for transvaginal pelvic organ prolapse repair is a prescription device intended to reinforce soft tissue in the pelvic floor. This device is a porous implant that is made of synthetic material, non-synthetic material, or a combination of synthetic and non-synthetic materials. This device does not include surgical mesh for other intended uses (§ 878.3300 of this chapter).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## 510(k) Summary for Pinnacle LITE Pelvic Floor Repair Kit, Posterior and Uphold LITE Vaginal Support System ## Date Prepared: Sep 30, 2013 #### A. Sponsor Boston Scientific Corporation Urology and Gynecology Division 100 Boston Scientific Way Marlborough, MA 01756 #### B. Contact Michelle Berry Senior, Regulatory Affairs Specialist 508-683-4941 or Donna Gardner Director, Regulatory Affairs 508-683-4398 ## C. Device Name | Trade name: | Pinnacle LITE Pelvic Floor Repair Kit, Posterior and Uphold LITE Vaginal Support System | |----------------------|-----------------------------------------------------------------------------------------------------------------------------| | Common/usual name: | Surgical Mesh | | Classification Name: | OTP - Mesh, Surgical, Synthetic, Urogynecologic, for Pelvic Organ Prolapse, Transvaginally Placed 21 CFR 878.3300, Class II | #### D. Predicate Device(s) | Trade name: | Pinnacle LITE Pelvic Floor Repair Kit, Posterior and<br>Uphold LITE Vaginal Support System | |-------------------------|-----------------------------------------------------------------------------------------------------------------------------------| | Common/usual name: | Surgical Mesh | | Classification Name: | OTP – Mesh, Surgical, Synthetic, Urogynecologic, for<br>Pelvic Organ Prolapse, Transvaginally Placed<br>21 CFR 878.3300, Class II | | Premarket Notification: | Boston Scientific, K103426 | ## E. Device Description The proposed devices were submitted for a leg assembly modification to the previously cleared LITE Pelvic Floor Repair Kits: Pinnacle LITE Posterior and Uphold LITE Vaginal Support System. The modification to the leg assembly removes the mesh tack welds, separator weld and adds a second leader loop to maintain the mesh leg location within the sleeve to facilitate mesh leg placement. There are no changes to the mesh design, shape, size, material or indications for use. {1}------------------------------------------------ The proposed mesh configurations were designed for performing transvaginal vaginal wall repair to facilitate treatment of anterior apical and posterior prolapse repairs. These devices are sterile, single use devices, consisting of one lightweight synthetic mesh assembly and a needle holder. The mesh assembly consists of a macroporous polypropylene knitted mesh body with integrated legs that are protected by disposable polymer sleeves. At the distal end of the disposable polymer sleeve is a lead with dart designed for use with the Capio™ Suture Capturing Device. The disposable lead was designed to facilitate the passage of the proposed mesh through bodily tissues for placement. ### F. Intended Use The Pinnacle LITE Pelvic Floor Repair Kit is indicated for tissue reinforcement in women with pelvic organ prolapse, for transvaginal repair of posterior vaginal vault prolapse. The Uphold LITE Vaginal Support System is indicated for tissue reinforcement in women with pelvic organ prolapse, for the transvaginal repair of anterior and apical vaginal wall prolapse. ### G. Technological Characteristics The proposed device has the same identical mesh fiber materials and fiber diameter as the predicate. The leg assembly will include a second leader loop to maintain the mesh leg location within the sleeve to facilitate mesh leg placement. #### H. Substantial Equivalence Utilizing FDA's Guidance for Industry and FDA Staff "Format for Traditional and Abbreviated 510(k)s" and "Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh", a direct comparison of key characteristics demonstrates that the proposed mesh is substantially equivalent to the predicate mesh in terms of intended use, technological characteristics, and performance characteristics. The proposed device is as safe, as effective, and performs as well as the predicate devices. #### I. Performance Testing (Bench Evaluation) Boston Scientific conducted performance testing in support of the leg assembly change and the following testing was completed: - Leg Assembly Flexibility - Mesh/Leg Tensile . - Leader/Dilator/Sleeve Tensile ● - . Sleeve Removal The results of the performance testing demonstrate equivalence of the proposed and predicate devices. The LITE Pelvic Floor Repair Kits are considered safe and effective for their intended use. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, symbolizing protection and care. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 November 18, 2013 Boston Scientific Corporation Urology and Women's Health Michelle M. Berry Principal Specialist, Regulatory Affairs 100 Boston Scientific Way Marlborough, MA 01752 Re: K122459 > Trade/Device Name: Pinnacle LITE Pelvic Floor Repair Kit, Posterior and Uphold LITE Vaginal Support System Regulation Number: 21 CFR§ 878.3300 Regulation Name: Surgical Mesh Regulatory Class: II Product Code: OTP Dated: (Date on orig SE Itr): November 2, 2012 Received: (Date on orig SE Itr): November 5, 2012 Dear Michelle M. Berry, This letter corrects our substantially equivalent letter of December 13, 2012. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to 28 May 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Michelle M. Berry Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Benjamin R. Fisher -S Benjamin R. Fisher, Ph.D. Director Division of Reproductive. Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure: {4}------------------------------------------------ ## Indications for Use Statement 510(k) Number (if Known): Device Name: Pinnacle LITE Pelvic Floor Repair Kit, Posterior and Uphold LITE Vaginal Support System #### Indications For Use: The Pinnacle LITE Pelvic Floor Repair Kit is indicated for tissue reinforcement in women with pelvic organ prolapse, for transvaginal repair of posterior vaginal vault prolapse. The Uphold LITE Vaginal Support System is indicated for tissue reinforcement in women with pelvic organ prolapse, for the transvaginal repair of anterior and apical vaginal wall prolapse. Prescription Use X (21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) # (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) # Benjamin R. Fisher -S 2013.11.18 17:01:46 -05'00'
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%